Solventum (SOLV) Non-Current Deferred Tax Liability (2023 - 2026)
Solventum (SOLV) reported Non-Current Deferred Tax Liability of $161.0 million for Q1 2026, down 28.76% on a YoY basis from $226.0 million in Q1 2025, and down 1.83% quarter-over-quarter from $164.0 million in Q4 2025.
Solventum (SOLV) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Solventum has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $161.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 28.76% year-over-year to $161.0 million; the trailing twelve-month figure through Mar 2026 stood at $161.0 million (down 28.76% YoY), and the FY2025 full-year result was $164.0 million, down 57.84% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $161.0 million, down from $164.0 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $448.0 million in Q4 2023, with the low at $161.0 million in Q1 2026.
- Historically, Non-Current Deferred Tax Liability has averaged $242.7 million across 4 years, with a median of $214.0 million in 2024.
- The largest YoY upside for Non-Current Deferred Tax Liability was 7.94% in 2025 against a maximum downside of 57.84% in 2025.
- Solventum's Non-Current Deferred Tax Liability stood at $448.0 million in 2023, then retreated by 13.17% to $389.0 million in 2024, then slumped by 57.84% to $164.0 million in 2025, then declined by 1.83% to $161.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $161.0 million (Q1 2026), $164.0 million (Q4 2025), and $169.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161.00 Mn |
| Mar 31, 2026 | 161.00 Mn |
| Dec 31, 2025 | 164.00 Mn |
| Dec 31, 2025 | 164.00 Mn |
| Sep 30, 2025 | 169.00 Mn |
| Sep 30, 2025 | 169.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Mar 31, 2025 | 226.00 Mn |
| Mar 31, 2025 | 226.00 Mn |
| Dec 31, 2024 | 389.00 Mn |
| Dec 31, 2024 | 389.00 Mn |
| Sep 30, 2024 | 214.00 Mn |
| Sep 30, 2024 | 214.00 Mn |
| Jun 30, 2024 | 214.00 Mn |
| Jun 30, 2024 | 214.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Dec 31, 2023 | 448.00 Mn |
| Dec 31, 2023 | 448.00 Mn |